Moximed Announces First-Ever Implantation of MISHA™ Knee System, a Breakthrough Implantable Shock Absorber for Knee Osteoarthritis

Sep 08, 2023 07:30 CST Updated 07:30

Moximed

Knee Osteoarthritis Medical Device Developer

Source: Bone Future; Editor: Jacky

Reprint requirements: You can directly repost, but please credit the source at the beginning of the article.

On September 6, 2023, Moximed, a medical device company dedicated to improving the standard of care for patients with knee osteoarthritis (OA), announced the completion of the first implantation surgery of its MISHA™ Knee System.

# MISHA Knee System Completes First Implantation

MISHA Knee System is an implantable shock absorber (ISA) for the knee, used to treat patients with medial compartment osteoarthritis of the knee. These patients often cannot find pain relief through non-surgical or surgical treatments, and the pain has interfered with daily activities. Additionally, they are unable to undergo joint replacement surgery due to age restrictions or other subjective reasons.

Osteoarthritis is the most common joint disease, with knee osteoarthritis accounting for over 80%, affecting at least 19% of individuals aged 45 and above.The above-mentioned impact on American adults.MISHA Knee System Was Launched in April 2023. Before That, If Conservative Treatment Didn't Work, Doctors and Most Patients Had Very Limited Treatment Options.

▲Image SourceOfficial CompanyNetwork (hereinafter the same)

Dennis C. Crawford, MD, Professor of Orthopedics and Rehabilitation at Oregon Health & Science University School of Medicine, treated the first patient with the MISHA system. Dr. Crawford expressed his honor in treating the first MISHA patient. The patient, in his 40s, presented with a medial meniscus lesion, significant medial knee pain, and mild joint space loss. Before the advent of the MISHA Knee System, there were not many good treatment options suitable for this patient. However, two weeks after the MISHA implantation, during the follow-up visit, the patient’s knee had regained full range of motion, was able to bear full weight, and he could walk comfortably. This outcome aligns with the results from the pivotal study.

Osteoarthritis (OA) is a common disease that affects the lives of more than 32 million adults in the United States and is expected to impact 70 million Americans by 2040. Knee osteoarthritis occurs when the body's natural shock absorbers, such as joints, cartilage, and menisci, no longer provide cushioning, leading to chronic pain and restricted movement. Many patients with mild to moderate osteoarthritis are otherwise healthy, in the prime of their working lives, and lead fairly busy lifestyles.

For these patients, total knee replacement is not the best choice, as the procedure is mainly aimed at patients with advanced osteoarthritis. The MISHA Knee System offers a solution for patients who have not yet progressed to late-stage osteoarthritis, providing knee protection while maintaining activity levels and quality of life.

# About MISHA Knee System

MISHA Knee System is a revolutionary implant designed for patients suffering from painful knee osteoarthritis. Overloading of the knee can lead to osteoarthritis, and reducing joint load allows the knee to move in a more favorable environment, alleviating pain for patients.

MISHA Knee System Designed with Patient Needs in Mind. The system is implanted beneath the skin but does not enter the joint cavity. The procedure is performed in an outpatient setting, with an average time from admission to discharge of approximately 9 hours, and no postoperative restrictions on weight-bearing or resumption of activities.

MISHA Knee System is designed to simplify surgery, requiring no bone cutting and preserving the articular cartilage surface of the knee, thus maintaining future treatment options. The surgery utilizes standard orthopedic instruments and dedicated instruments for the one-time implantable shock absorber, and the surgical techniques involved are also very familiar to orthopedic surgeons.

# About Moximed

Moximed, Inc. was founded in 2008 and is headquartered in California, USA. It is dedicated to helping patients with mild to moderate osteoarthritis protect their knee joints while living a healthy and active life. The company’s MISHA™ Knee System is the result of more than a decade of clinical research and development. It is the first implantable shock absorber developed for the treatment of medial compartment knee osteoarthritis (OA). With an experienced medical technology team and strong investor support, Moximed is poised to raise the standard of care and quality of life for millions of patients with knee osteoarthritis.

Click the keywords below, select "Subscribe" in the upper right corner, and get the latest information第一时间!

Orthopedic Company Inventory | Orthopedic Industry Research | Orthopedic New Products